Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans

Florencia Halperin, Ximena Lopez, Raquel Manning, C. Ronald Kahn, Rohit N. Kulkarni, Allison B. Goldfine

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Type 2 diabetes (T2D) is characterized by insulin resistance and pancreatic β-cell dysfunction, the latter possibly caused by a defect in insulin signaling in β-cells. We hypothesized that insulin's effect to potentiate glucose-stimulated insulin secretion (GSIS) would be diminished in insulin-resistant persons. To evaluate the effect of insulin to modulate GSIS in insulin-resistant compared with insulin-sensitive subjects, 10 participants with impaired glucose tolerance (IGT), 11 with T2D, and 8 healthy control subjects were studied on two occasions. The insulin secretory response was assessed by the administration of dextrose for 80 min following a 4-h clamp with either saline infusion (sham) or an isoglycemic-hyperinsulinemic clamp using B28- Asp-insulin (which can be distinguished immunologically from endogenous insulin) that raised insulin concentrations to high physiologic concentrations. Pre-exposure to insulin augmented GSIS in healthy persons. This effect was attenuated in insulinresistant cohorts, both those with IGT and those with T2D. Insulin potentiates glucose-stimulated insulin secretion in insulin-resistant subjects to a lesser degree than in normal subjects. This is consistent with an effect of insulin to regulate b-cell function in humans in vivo with therapeutic implications.

Original languageEnglish (US)
Pages (from-to)301-309
Number of pages9
JournalDiabetes
Volume61
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Insulin
Glucose
Type 2 Diabetes Mellitus
Glucose Intolerance
Insulin Aspart
Insulin Resistance
Healthy Volunteers

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Halperin, F., Lopez, X., Manning, R., Kahn, C. R., Kulkarni, R. N., & Goldfine, A. B. (2012). Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. Diabetes, 61(2), 301-309. https://doi.org/10.2337/db11-1067

Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. / Halperin, Florencia; Lopez, Ximena; Manning, Raquel; Kahn, C. Ronald; Kulkarni, Rohit N.; Goldfine, Allison B.

In: Diabetes, Vol. 61, No. 2, 02.2012, p. 301-309.

Research output: Contribution to journalArticle

Halperin, F, Lopez, X, Manning, R, Kahn, CR, Kulkarni, RN & Goldfine, AB 2012, 'Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans', Diabetes, vol. 61, no. 2, pp. 301-309. https://doi.org/10.2337/db11-1067
Halperin, Florencia ; Lopez, Ximena ; Manning, Raquel ; Kahn, C. Ronald ; Kulkarni, Rohit N. ; Goldfine, Allison B. / Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. In: Diabetes. 2012 ; Vol. 61, No. 2. pp. 301-309.
@article{4af5429695da4562982642e53d664288,
title = "Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans",
abstract = "Type 2 diabetes (T2D) is characterized by insulin resistance and pancreatic β-cell dysfunction, the latter possibly caused by a defect in insulin signaling in β-cells. We hypothesized that insulin's effect to potentiate glucose-stimulated insulin secretion (GSIS) would be diminished in insulin-resistant persons. To evaluate the effect of insulin to modulate GSIS in insulin-resistant compared with insulin-sensitive subjects, 10 participants with impaired glucose tolerance (IGT), 11 with T2D, and 8 healthy control subjects were studied on two occasions. The insulin secretory response was assessed by the administration of dextrose for 80 min following a 4-h clamp with either saline infusion (sham) or an isoglycemic-hyperinsulinemic clamp using B28- Asp-insulin (which can be distinguished immunologically from endogenous insulin) that raised insulin concentrations to high physiologic concentrations. Pre-exposure to insulin augmented GSIS in healthy persons. This effect was attenuated in insulinresistant cohorts, both those with IGT and those with T2D. Insulin potentiates glucose-stimulated insulin secretion in insulin-resistant subjects to a lesser degree than in normal subjects. This is consistent with an effect of insulin to regulate b-cell function in humans in vivo with therapeutic implications.",
author = "Florencia Halperin and Ximena Lopez and Raquel Manning and Kahn, {C. Ronald} and Kulkarni, {Rohit N.} and Goldfine, {Allison B.}",
year = "2012",
month = "2",
doi = "10.2337/db11-1067",
language = "English (US)",
volume = "61",
pages = "301--309",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "2",

}

TY - JOUR

T1 - Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans

AU - Halperin, Florencia

AU - Lopez, Ximena

AU - Manning, Raquel

AU - Kahn, C. Ronald

AU - Kulkarni, Rohit N.

AU - Goldfine, Allison B.

PY - 2012/2

Y1 - 2012/2

N2 - Type 2 diabetes (T2D) is characterized by insulin resistance and pancreatic β-cell dysfunction, the latter possibly caused by a defect in insulin signaling in β-cells. We hypothesized that insulin's effect to potentiate glucose-stimulated insulin secretion (GSIS) would be diminished in insulin-resistant persons. To evaluate the effect of insulin to modulate GSIS in insulin-resistant compared with insulin-sensitive subjects, 10 participants with impaired glucose tolerance (IGT), 11 with T2D, and 8 healthy control subjects were studied on two occasions. The insulin secretory response was assessed by the administration of dextrose for 80 min following a 4-h clamp with either saline infusion (sham) or an isoglycemic-hyperinsulinemic clamp using B28- Asp-insulin (which can be distinguished immunologically from endogenous insulin) that raised insulin concentrations to high physiologic concentrations. Pre-exposure to insulin augmented GSIS in healthy persons. This effect was attenuated in insulinresistant cohorts, both those with IGT and those with T2D. Insulin potentiates glucose-stimulated insulin secretion in insulin-resistant subjects to a lesser degree than in normal subjects. This is consistent with an effect of insulin to regulate b-cell function in humans in vivo with therapeutic implications.

AB - Type 2 diabetes (T2D) is characterized by insulin resistance and pancreatic β-cell dysfunction, the latter possibly caused by a defect in insulin signaling in β-cells. We hypothesized that insulin's effect to potentiate glucose-stimulated insulin secretion (GSIS) would be diminished in insulin-resistant persons. To evaluate the effect of insulin to modulate GSIS in insulin-resistant compared with insulin-sensitive subjects, 10 participants with impaired glucose tolerance (IGT), 11 with T2D, and 8 healthy control subjects were studied on two occasions. The insulin secretory response was assessed by the administration of dextrose for 80 min following a 4-h clamp with either saline infusion (sham) or an isoglycemic-hyperinsulinemic clamp using B28- Asp-insulin (which can be distinguished immunologically from endogenous insulin) that raised insulin concentrations to high physiologic concentrations. Pre-exposure to insulin augmented GSIS in healthy persons. This effect was attenuated in insulinresistant cohorts, both those with IGT and those with T2D. Insulin potentiates glucose-stimulated insulin secretion in insulin-resistant subjects to a lesser degree than in normal subjects. This is consistent with an effect of insulin to regulate b-cell function in humans in vivo with therapeutic implications.

UR - http://www.scopus.com/inward/record.url?scp=84856537444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856537444&partnerID=8YFLogxK

U2 - 10.2337/db11-1067

DO - 10.2337/db11-1067

M3 - Article

VL - 61

SP - 301

EP - 309

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 2

ER -